Thermo Fisher announces $3.1bn acquisition of proteomics leader Olink
In a transformative move within the life sciences domain, Thermo Fisher Scientific Inc. is set to acquire proteomics pioneer Olink Holding AB for a compelling cash deal of $26 per share, tallying to a transactional value of around $3.1 billion. This offer marks a 74% premium on Olink’s ADS (American Depositary Shares) closing price from […]